News
Client MNRs and Landing Pages
Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.
Let's talkSearch our recent client collaborations below:
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 4, 2026Size-Inclusive design house Renee Cafaro Atelier, debuted a plus size ready-to-wear sublabel RCA Public Label in 2021, and quickly became known for their innovative fit, and best-selling Game Changer Dress, featuring Cafaro’s patented built-in bra technologyCreate your Dream Wardrobe Now Size-inclusive Clothing Brand Public Label Reboots as a Customizable Portal New York, NY - Size-Inclusive design house Renee Cafaro Atelier, debuted a plus size...
-
May 1, 2026Inspired by MSC Cruises’ exclusive onboard MSC Yacht Club concept, the hospitality experience is set to transform the brand’s signature “ship-within-a-ship” experience into a one-of-a-kind race weekend experience
Learn More MSC CRUISES TO BRING EXCLUSIVE MSC YACHT CLUB EXPERIENCE TRACKSIDE AT 2026 FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX Inspired by MSC Cruises’ exclusive onboard MSC Yacht Club concept,...
-
May 1, 2026Inspirada en la experiencia exclusiva dentro de los barcos de MSC Cruises, el MSC Yacht Club llevará su concepto de “barco dentro de un barco” a la pista creando un fin de semana único durante de la carrera.
Aprende Más MSC CRUISES PRESENTA LA EXPERIENCIA EXCLUSIVA MSC YACHT CLUB DURANTE EL 2026 FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX Inspirada en la experiencia exclusiva dentro de los barcos de MSC...
May 1, 2026New data from the American Academy of Dermatology reveals misinformation drives adults to cut back or stop using sunscreenFind a Board-Certified Dermatologist Near You Misinformation puts over 16 million Americans at an increased risk for skin cancer New data from the American Academy of Dermatology reveals...
May 1, 2026AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to Alzheimer’s diseaseAxsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease AUVELITY is a...
Connect with us: